San Diego, California--(Newsfile Corp. - December 23, 2025) - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors.If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and ...

SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and ...

Core Viewpoint - Edelson Lechtzin LLP is investigating Ardent Health, Inc. for potential violations of federal securities laws due to allegations of misleading business information provided to investors [1]. Company Overview - Ardent Health, founded in 2001, operates a network of 30 hospitals and over 280 care locations across six states, catering to mid-sized communities with a diverse range of healthcare services [2]. Alleged Wrongdoing - On November 12, 2025, Ardent Health reported third-quarter results that did not meet expectations, primarily due to an increase in insurance claim denials and a $54 million adjustment related to prior claims and litigation in New Mexico involving a former provider [3]. - The company revised its accounting estimates, leading to an earlier recognition of reserves, which resulted in a $43 million reduction in reported revenue for the quarter [3]. - Following this announcement, Ardent Health's stock price dropped by over 33% on November 13, 2025 [4].

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation. Why Is Ardent being Investigated for Securities Violations?Ardent is a provider of healthcare in mid-sized urban communities ...

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLPis investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT), focused on whether Ardent Health and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and would like to ...

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation. Why Is Ardent being Investigated for Securities Violations? Ardent is a provider of healthcare in mid-sized urban communitie ...

Core Insights - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc., focusing on whether the company and its executives made false or misleading statements or failed to disclose material information to investors [1] Company Overview - Ardent Health is a healthcare provider operating in growing midsize urban communities across the United States [3] - The company raised $192 million in its initial public offering on July 18, 2024, selling 12 million shares at $16 per share [3] Recent Developments - On November 12, 2025, Ardent Health announced its third quarter 2025 earnings, missing consensus estimates primarily due to pronounced payor denials and a $54 million adjustment related to adverse prior period claim developments from 2019 to 2022 [4] - The CFO, Alfred Lumsdaine, indicated that a "change in accounting estimate" led to the earlier recognition of reserves, resulting in a revenue reduction of $43 million for the quarter [4]

ARDT NOTIFICATION: BFA Law Notifies Ardent Health, Inc. Investors of the Pending Class Action Investigation and to Contact the Firm if You Lost MoneyDecember 10, 2025 7:17 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - December 10, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to ob ...

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][2]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue after conducting evaluations of historical collection trends [3]. - The company increased its professional liability reserves by $54 million due to adverse developments from claims between 2019 and 2022, as well as broader industry trends [3]. Stock Market Reaction - Following the financial report on November 12, 2025, Ardent's stock price dropped over 33% during trading on November 13, 2025 [3].

Core Insights - Holzer & Holzer, LLC is investigating Ardent Health, Inc. for potential compliance issues with federal securities laws following a significant revenue decrease reported in Q3 2025 [1] - Ardent announced a revenue decrease of $43 million due to changes in accounting estimates related to accounts receivable collectability [1] Company Performance - In Q3 2025, Ardent Health reported a revenue decrease attributed to modifications in accounting techniques and new evaluations of historical collection trends [1] - The announcement of the revenue decrease led to a decline in the company's stock price [1]